Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - AccuredRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Metagenomi (MGX) Current Assets (2023 - 2025)

Metagenomi (MGX) has disclosed Current Assets for 3 consecutive years, with $165.5 million as the latest value for Q4 2025.

  • On a quarterly basis, Current Assets fell 35.83% to $165.5 million in Q4 2025 year-over-year; TTM through Dec 2025 was $165.5 million, a 35.83% decrease, with the full-year FY2025 number at $165.5 million, down 35.83% from a year prior.
  • Current Assets was $165.5 million for Q4 2025 at Metagenomi, down from $189.8 million in the prior quarter.
  • In the past five years, Current Assets ranged from a high of $335.6 million in Q1 2024 to a low of $165.5 million in Q4 2025.
  • A 3-year average of $251.3 million and a median of $258.0 million in 2024 define the central range for Current Assets.
  • Peak YoY movement for Current Assets: fell 7.3% in 2024, then crashed 35.83% in 2025.
  • Metagenomi's Current Assets stood at $278.3 million in 2023, then dropped by 7.3% to $258.0 million in 2024, then plummeted by 35.83% to $165.5 million in 2025.
  • Per Business Quant, the three most recent readings for MGX's Current Assets are $165.5 million (Q4 2025), $189.8 million (Q3 2025), and $211.7 million (Q2 2025).